हिन्दी
India gives a nod to Virafin by Zydus Cadila for treatment of moderate COVID-19 symptoms. Virafin went under clinical trials supported under DBT-BIRAC COVID 19 Research Consortium.
Virafin by Zydus Cadila approved for treating moderate Covid-19
India gives a nod to Virafin by Zydus Cadila for treatment of moderate COVID-19 symptoms. Virafin went under clinical trials supported under DBT-BIRAC COVID 19 Research Consortium.
clinical trials COVID-19 Covid-19 Updates DBT-BIRAC COVID 19 Research Consortium Virafin Virafin by Zydus Cadila
You may also read!
The Impact of second hand smoke on non-smokers.
Do you know what exactly is second hand smoking? Well it can be as dangerous
Tobacco use and the risk of Cancer recurrence
ven after cancer treatment,when the disease comes back or returns, That is called a cancer
The Economics of tobacco production and Its Impact on Society
It's time to uncover the staggering figures behind the global tobacco market and learn
